<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28386" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Chronic Traumatic Encephalopathy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Munakomi</surname>
            <given-names>Sunil</given-names>
          </name>
          <aff>Kathmandu University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Puckett</surname>
            <given-names>Yana</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sunil Munakomi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yana Puckett declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>10</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28386.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Chronic traumatic encephalopathy (CTE), formerly known as repetitive head injury syndrome, is a progressive neurodegenerative disorder commonly observed in individuals involved in contact sports or military service. This condition is characterized by specific brain abnormalities, including regional atrophy, ventriculomegaly, and the deposition of neurofibrillary tangles and neuropil threads, contributing to a distinct form of tauopathy. Although CTE can only be definitively diagnosed postmortem, recent consensus guidelines provide criteria for identifying its clinical manifestations, referred to as traumatic encephalopathy syndrome.&#x000a0;The clinical presentation of CTE varies, with younger individuals often exhibiting mood and behavioral symptoms, while older patients may experience cognitive impairments.&#x000a0;The disease progresses through stages, eventually leading to severe cognitive dysfunction and neurodegeneration.</p>
        <p>CTE currently has no cure, and treatment primarily focuses on managing symptoms. Research highlights the need for prospective, longitudinal studies incorporating fluid and imaging biomarkers to improve the understanding and management of the condition.&#x000a0;This activity comprehensively reviews chronic transplant rejection, covering its characteristics, historical background, diagnostic criteria, and postmortem diagnosis. This activity also delves into recent advancements in imaging techniques and potential fluid biomarkers alongside current management approaches and preventive strategies. In addition, this activity enhances healthcare providers' knowledge and skills in effective management and prevention strategies for chronic transplant rejection, emphasizing interprofessional collaboration to improve patient outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the clinical manifestations and progression stages of chronic traumatic encephalopathy to improve early recognition and diagnosis.</p></list-item><list-item><p>Screen individuals at high risk for chronic traumatic encephalopathy, including athletes and military personnel, using appropriate diagnostic tools and criteria.</p></list-item><list-item><p>Assess the progression of chronic traumatic encephalopathy in patients through regular neurological evaluations and imaging studies, adjusting management strategies as needed.</p></list-item><list-item><p>Collaborate with multidisciplinary healthcare teams, including sports medicine professionals, mental health specialists, and researchers, to provide comprehensive care for individuals with chronic traumatic encephalopathy.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28386&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28386">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-28386.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Chronic traumatic encephalopathy (CTE), formerly known as repetitive&#x000a0;head injury syndrome, is a progressive neurodegenerative condition commonly observed in individuals involved in contact sports or military service associated with an increased risk of repeated head injuries. This condition is characterized by regional atrophy, ventriculomegaly, and specific brain abnormalities.<xref ref-type="bibr" rid="article-28386.r1">[1]</xref>&#x000a0;Historically, CTE has been linked to repeated head trauma, with early descriptions highlighting its association with "punch drunk" syndrome and ''dementia pugilistica" in boxers. The condition has evolved into a significant topic within the sports medicine community, with ongoing investigations into its pathophysiology, diagnostic criteria, and potential therapeutic approaches.<xref ref-type="bibr" rid="article-28386.r1">[1]</xref><xref ref-type="bibr" rid="article-28386.r2">[2]</xref></p>
        <p>
<bold>Historical Background</bold>
</p>
        <p>Harrison Martland was the first to mention "perivascular microhemorrhages" that progressively evolved into "replacement gliosis," resulting in punch drunk syndrome. Abram Bowman and Karl Blau then coined the term CTE to better characterize the condition. N. Corsellis subsequently identified neurofibrillary tangles (NFTs), along with ventricular dilatation, cavum septum pellucidum, thinning of the corpus callosum, and cerebellar tonsillar scarring in affected individuals. Additional neuropathological changes in CTE were later documented by Jennian Geddes, who noted perivascular neurofibrillary encasement within cortical sulci, and Bennet Omalu, who described amyloid plaques, tau-positive neurofibrillary tangles, and neuropil threads associated with the condition.</p>
        <p>Ann McKee proposed neuropathological diagnostic and grading criteria for CTE, characterized by patchy deposits of phosphorylated tau (p-tau)&#x02013;positive NFTs and astrocytic&#x000a0;tangles located perivascularly within the neocortex, at the depths of cerebral sulci, and in the superficial layers of the cortex, primarily in the temporal lobe. The National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have established criteria for diagnosing CTE, focusing on perivascular foci of p-tau NFTs and astrocytic tangles in the cortex, with a preference for their presence at sulcal depths and in the superficial layers of the cerebral cortex.&#x000a0;</p>
        <p>In 2021, the panel refined the definition of the pathognomonic lesion to emphasize that perivascular p-tau aggregates must involve neurons and extend deeper than the subpial layer. Additionally, the panel introduced the classifications "Low CTE" and "High CTE" to indicate the presence of NFTs in specific brain regions, such as the thalamus, mammillary bodies, hippocampus, amygdala, and entorhinal cortex, to assist neuropathologists in their assessments.<xref ref-type="bibr" rid="article-28386.r3">[3]</xref>&#x000a0;</p>
        <p>While CTE can only be definitively diagnosed through postmortem examination, recent consensus guidelines have established criteria for identifying its clinical manifestations, referred to as traumatic encephalopathy syndrome (TES).<xref ref-type="bibr" rid="article-28386.r4">[4]</xref> Montenegro et al proposed the clinical diagnostic criteria for CTE comprising cognitive, behavioral, and mood symptomatology as 3 core elements alongside 9 other supportive features, including impulsivity, anxiety, apathy, paranoia, suicidality, headache, motor signs, documented decline, and delayed onset.<xref ref-type="bibr" rid="article-28386.r5">[5]</xref></p>
      </sec>
      <sec id="article-28386.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Repeated head injury is crucial in the genesis of CTE, with a strong causal relationship established between repeated trauma and the condition.<xref ref-type="bibr" rid="article-28386.r3">[3]</xref>&#x000a0;Repeated head injury exposure is the only known unifying factor and is present in 97% of patients among the more than 600 CTE cases reported in the literature.<xref ref-type="bibr" rid="article-28386.r3">[3]</xref>&#x000a0;Computational models and animal studies involving Musk oxen and bighorn sheep&#x02014;both with gyrencephalic brains (with sulci) and engaged in combative headbutting&#x02014;have shown positive correlations between repeated head injury and CTE.<xref ref-type="bibr" rid="article-28386.r3">[3]</xref>&#x000a0;</p>
        <p>An association exists between cognitive reserve, demographic factors (eg, early age of first exposure), and exposure metrics (eg, cumulative head impact index) with the severity of future neurological sequelae.<xref ref-type="bibr" rid="article-28386.r1">[1]</xref><xref ref-type="bibr" rid="article-28386.r6">[6]</xref>&#x000a0;A consistent dose-response relationship has been validated between cumulative years of playing contact sports, such as American football and ice hockey, and both the onset and severity of CTE.<xref ref-type="bibr" rid="article-28386.r3">[3]</xref>&#x000a0;Additionally, the APOE epsilon-4 allele has been shown to predict an increased risk of developing cognitive decline following repeated head impacts.<xref ref-type="bibr" rid="article-28386.r1">[1]</xref></p>
      </sec>
      <sec id="article-28386.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Approximately 4 million sports-related concussions are reported annually in the United States alone.<xref ref-type="bibr" rid="article-28386.r1">[1]</xref> The incidence of sport-related neurological conditions among boxers is reported to be 17%. In a study conducted by the Mayo Clinic Brain Bank, CTE pathology was found in 32% of athletes who participated in contact sports. Similarly, in the largest case series of 177 former professional football players, CTE was diagnosed in up to 87% of the patients.<xref ref-type="bibr" rid="article-28386.r1">[1]</xref>&#x000a0;A recent study has also revealed significant neuropathological evidence of CTE among football players who donated their brains for research.<xref ref-type="bibr" rid="article-28386.r7">[7]</xref></p>
      </sec>
      <sec id="article-28386.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Tau protein regulates the assembly of tubulin into microtubules, thereby maintaining the structural integrity of axons.&#x000a0;Tau phosphorylation mediates tau's binding to microtubules.&#x000a0;Tau proteins dissociate from microtubules in axons due to calcium influx and glutamate hyperexcitotoxicity. Calcium influx activates caspases, while glutamate hyperexcitotoxicity causes cytoskeletal failure. These disruptions lead to kinase-mediated hyperphosphorylation, misfolding, and aggregation of tau, which is then proteolytically cleaved by calpains and caspases.<xref ref-type="bibr" rid="article-28386.r8">[8]</xref><xref ref-type="bibr" rid="article-28386.r9">[9]</xref>&#x000a0;These processes, including tau phosphorylation, misfolding, shortening, and aggregation, contribute to NFT deposition.<xref ref-type="bibr" rid="article-28386.r9">[9]</xref>&#x000a0;</p>
        <p>TAR DNA-binding protein 43 (TDP-43) inclusions and amyloid-&#x003b2; deposition are also observed in CTE. Perivascular polarization of astroglial aquaporin-4 impairs glymphatic clearance.<xref ref-type="bibr" rid="article-28386.r9">[9]</xref>&#x000a0;The combination of excessive protein deposition and reduced clearance aggravates the neurodegenerative process.&#x000a0;Oxidative stress, neuroinflammation, and glutaminergic toxicity contribute significantly to CTE pathogenesis. Chronic inflammation disrupts the ubiquitin-proteasome pathway, while microglial priming leads to immune-excitotoxic responses and persistent neurodegeneration.<xref ref-type="bibr" rid="article-28386.r9">[9]</xref>&#x000a0;</p>
        <p>Immuno-excitotoxicity is critical in the pathogenesis of&#x000a0;CTE. Repeatedly primed microglia, after a repetitive head injury, fail to transition from a neuro-destructive mode to a reparative mode. This failure exacerbates the inflammatory insult to the brain by providing a favorable milieu amidst glutamate toxicity.<xref ref-type="bibr" rid="article-28386.r10">[10]</xref>&#x000a0;Excitotoxicity also generates reactive oxygen and nitrogen species.<xref ref-type="bibr" rid="article-28386.r9">[9]</xref> Repeated head injury causes axonal degeneration and microtubular disintegration, leading to tau oligomerization. This oligomerization progresses to the formation of NFTs, affecting neuronal crosstalk and networking. This disruption eventually results in tau propagation, which triggers inflammatory cascades and ultimately impairs blood-brain barrier permeability.<xref ref-type="bibr" rid="article-28386.r11">[11]</xref></p>
      </sec>
      <sec id="article-28386.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Gross examination reveals features of regional atrophy, most commonly in the frontal lobe, along with ventriculomegaly, wasting of the corpus callosum, and characteristic fenestration of the septum pellucidum. The regions of atrophy parallel high concentrations of glutamate receptors, thereby connoting excitotoxicity's role in the entity's pathogenesis.<xref ref-type="bibr" rid="article-28386.r1">[1]</xref></p>
        <p>Microscopically, the predominant findings include the deposition of NFTs and neuropil threads. In CTE, NFTs are deposited perivascularly at the sulcal depths and are exclusively neuronal.<xref ref-type="bibr" rid="article-28386.r3">[3]</xref><xref ref-type="bibr" rid="article-28386.r12">[12]</xref>&#x000a0;4R isomers are predominant in stages I&#x000a0;and II, while 3R isomers are more prevalent in stages III and IV.<xref ref-type="bibr" rid="article-28386.r3">[3]</xref>&#x000a0;Perivascular tau deposition within the sulcal depths is a critical criterion for diagnosing CTE, according to the first consensus from the NINDS and NIBIB.<xref ref-type="bibr" rid="article-28386.r1">[1]</xref>&#x000a0;The presence of neuronal p-tau is significantly associated with age, years of repeated head injury exposure, and the severity of CTE.<xref ref-type="bibr" rid="article-28386.r3">[3]</xref></p>
        <p>The following 4 histomorphologic phenotypes have been associated with CTE:</p>
        <list list-type="bullet">
          <list-item>
            <p>Type 1: NFTs and neuropil threads are present&#x000a0;only in the cerebral cortex and brainstem.</p>
          </list-item>
          <list-item>
            <p>Type 2: Type 1 features along with amyloid-&#x003b2; deposition.</p>
          </list-item>
          <list-item>
            <p>Type 3: NFTs and neuropil threads are found exclusively in the brainstem.</p>
          </list-item>
          <list-item>
            <p>Type 4: NFTs&#x000a0;and neuropil threads in the cortex, subcortex, brainstem, and basal ganglia, with the cerebellum being spared.<xref ref-type="bibr" rid="article-28386.r13">[13]</xref></p>
          </list-item>
        </list>
        <p>The Understanding Neurologic Injury in Traumatic Encephalopathy (UNITE) study, funded by the NINDS, also described patchy and perivascular deposits of NFTs in astrocytes and at the depths of the sulci.<xref ref-type="bibr" rid="article-28386.r14">[14]</xref>&#x000a0;As established by the NINDS panel consensus, the pattern of p-tau in CTE is distinct from other neurodegenerative conditions.<xref ref-type="bibr" rid="article-28386.r14">[14]</xref> Hallmarks include the superficial distribution of NFTs in layers II and III, patchy distribution of NFTs, and a perivascular pattern within the depths of the cortical sulci.<xref ref-type="bibr" rid="article-28386.r3">[3]</xref>&#x000a0;Brainstem p-tau pathology is considered a supportive feature of CTE.<xref ref-type="bibr" rid="article-28386.r3">[3]</xref>&#x000a0;P-tau spares the calcarine cortex even in the advanced stage.<xref ref-type="bibr" rid="article-28386.r9">[9]</xref></p>
      </sec>
      <sec id="article-28386.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The medical history typically includes some form of repetitive head trauma, often involving individuals who participate in contact sports or serve in the military. A thorough neurologic examination is crucial, with a particular emphasis on mental status assessment.<xref ref-type="bibr" rid="article-28386.r1">[1]</xref> Younger individuals are more likely to present with mood and behavior symptoms, while older individuals commonly exhibit cognitive impairment and executive dysfunction.<xref ref-type="bibr" rid="article-28386.r3">[3]</xref>&#x000a0;Cognitive symptoms increase the odds of CTE by 3.6-fold.<xref ref-type="bibr" rid="article-28386.r14">[14]</xref> During longitudinal follow-up, patients with a history of recurrent concussions tend to have a higher burden of cognitive, sleep, and neuropsychiatric symptoms but not migraine symptoms.<xref ref-type="bibr" rid="article-28386.r2">[2]</xref>&#x000a0;</p>
        <p>As described by Browne, the disease process begins with affective disturbances, followed by a stage of social instability and behavioral changes, with subtle features of early Parkinsonism. This eventually progresses to a third stage characterized by cognitive dysfunction, dementia, and full-blown Parkinsonism.<xref ref-type="bibr" rid="article-28386.r15">[15]</xref>&#x000a0;These changes have been attributed to the disease's impact on the Papez circuit.<xref ref-type="bibr" rid="article-28386.r16">[16]</xref>&#x000a0;</p>
        <p>The research diagnostic criteria describe 4 subtypes of CTE, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Behavioral or mood variant</p>
          </list-item>
          <list-item>
            <p>Cognitive variant</p>
          </list-item>
          <list-item>
            <p>Mixed variant</p>
          </list-item>
          <list-item>
            <p>Dementia form&#x000a0;<xref ref-type="bibr" rid="article-28386.r1">[1]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28386.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Montenegro et al proposed the following clinical diagnostic criteria for CTE:</p>
        <list list-type="bullet">
          <list-item>
            <p>A history of multiple head impacts</p>
          </list-item>
          <list-item>
            <p>Exclusion of other clinical mimics</p>
          </list-item>
          <list-item>
            <p>Symptomatology present for at least 12 months</p>
          </list-item>
          <list-item>
            <p>A minimum of 1 core and 2 supportive elements present<xref ref-type="bibr" rid="article-28386.r17">[17]</xref></p>
          </list-item>
        </list>
        <p>The core elements comprise cognitive symptoms (eg, episodic memory, executive function, and attention), behavioral (eg, verbal or physical aggression), and mood symptoms (eg, feeling depressed or hopeless).<xref ref-type="bibr" rid="article-28386.r14">[14]</xref>&#x000a0;As CTE can only be definitively diagnosed through postmortem neuropathologic findings, the NINDS consensus developed guidelines to aid in the clinical identification of TES.<xref ref-type="bibr" rid="article-28386.r4">[4]</xref></p>
        <p>The 4 primary diagnostic criteria proposed by the NINDS consensus for TES include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Substantial exposure to&#x000a0;repeated head injury</p>
          </list-item>
          <list-item>
            <p>Core clinical features such as cognitive impairment (eg, episodic memory and executive functioning)&#x000a0;and neurobehavioral dysregulation (eg, explosiveness, impulsivity, rage, violent outbursts, and emotional lability) with a progressive course</p>
          </list-item>
          <list-item>
            <p>Clinical features not fully accounted for by other disorders&#x000a0;<xref ref-type="bibr" rid="article-28386.r3">[3]</xref></p>
          </list-item>
        </list>
        <p>However, these criteria have a high risk of false positives, with nearly 54% of cognitively normal individuals receiving a consensus diagnosis. Additionally, there is a lack of spatial correlation between TES and head injury exposure.<xref ref-type="bibr" rid="article-28386.r18">[18]</xref>&#x000a0;The degree&#x000a0;of depression is the only significant predictor of a positive TES diagnosis.<xref ref-type="bibr" rid="article-28386.r18">[18]</xref>&#x000a0;</p>
        <p>Although CTE is confirmed through postmortem autopsy, the diagnosis is facilitated by immunohistochemistry for p-tau.<xref ref-type="bibr" rid="article-28386.r6">[6]</xref><xref ref-type="bibr" rid="article-28386.r11">[11]</xref>&#x000a0;Recent advances in imaging armamentarium and fluid biomarkers can also provide valuable input to support the diagnosis.<xref ref-type="bibr" rid="article-28386.r11">[11]</xref><xref ref-type="bibr" rid="article-28386.r19">[19]</xref><xref ref-type="bibr" rid="article-28386.r20">[20]</xref>&#x000a0;Growing evidence supports the role of the regional tau standardized uptake value ratio in flortaucipir positron-emission tomography (PET) and florbetapir PET for facilitating diagnosis,<xref ref-type="bibr" rid="article-28386.r14">[14]</xref>&#x000a0;although the specificity remains poorly documented.<xref ref-type="bibr" rid="article-28386.r21">[21]</xref>&#x000a0;Specific prototypical patterns or regional volume differences have not been identified in PET imaging.<xref ref-type="bibr" rid="article-28386.r22">[22]</xref></p>
        <p>A significant correlation has been observed only in the superior frontal region and among individuals aged 60 or older.<xref ref-type="bibr" rid="article-28386.r23">[23]</xref>&#x000a0;Furthermore, off-target binding in the hippocampus and thalamus complicates the interpretation of imaging results.<xref ref-type="bibr" rid="article-28386.r21">[21]</xref>&#x000a0;Other&#x000a0;important radiological features include concurrent cavum septum pellucidum and reduced fractional anisotropy in the corpus callosum and medial temporal white matter.<xref ref-type="bibr" rid="article-28386.r14">[14]</xref><xref ref-type="bibr" rid="article-28386.r22">[22]</xref>&#x000a0;Magnetic resonance imaging (MRI) and PET imaging are essential for ruling out other clinical mimics.<xref ref-type="bibr" rid="article-28386.r22">[22]</xref></p>
        <p>Potential fluid biomarkers for CTE include glial fibrillary acidic protein (GFAP), neurofibrillary light chain (NfL), total tau, neuron-specific enolase (NSE), ubiquitin C-terminal hydrolase-1 (UCHL-1), S100B, myelin basic protein (MBP), microtubule-associated protein-2 (MAP-2), brain-derived neurotrophic factor (BDNF), microRNA, and microvesicles and exosomes.<xref ref-type="bibr" rid="article-28386.r14">[14]</xref><xref ref-type="bibr" rid="article-28386.r24">[24]</xref><xref ref-type="bibr" rid="article-28386.r25">[25]</xref>&#x000a0;However, plasma biomarkers do not correspond well with cerebrospinal fluid measures in cases of late repetitive head injury, thereby minimizing their&#x000a0;efficacy.<xref ref-type="bibr" rid="article-28386.r26">[26]</xref>&#x000a0;Therefore, consensus on the role of fluid biomarkers in managing CTE has yet to be established. However, a recent pivotal finding of a characteristic hydrophobic cavity within the &#x003b2;-helix of tau filaments from CTE has opened new avenues for identifying early diagnostic targets (see <bold>Image.</bold> Chronic Traumatic Encephalopathy).<xref ref-type="bibr" rid="article-28386.r27">[27]</xref></p>
      </sec>
      <sec id="article-28386.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Currently, a definitive treatment for CTE does not exist; therefore, multispectral supportive measures are the mainstay of management.<xref ref-type="bibr" rid="article-28386.r1">[1]</xref> Amantadine and guanfacine may offer benefits for cognitive and working memory deficits. Cognitive improvement can be supported through cognitive rehabilitation therapy, a Mediterranean diet, and aerobic exercise.<xref ref-type="bibr" rid="article-28386.r14">[14]</xref> Occupational rehabilitation should also be encouraged. Depression requires careful management due to the potential risk of suicidality.</p>
        <p>Antioxidants such as ascorbic acid, <italic toggle="yes">N</italic>-acetylcysteine, alpha-tocopherol (ie, vitamin E), carotenoids, and omega-3 fatty acids have been used to counteract reactive oxygen species and reactive nitrogen species. Salsalate, which inhibits the acetylation process before the phosphorylation of the paired helical filament-6 motif and thereby suppresses microglial activation, is under research.<xref ref-type="bibr" rid="article-28386.r11">[11]</xref>&#x000a0;Ongoing research also focuses on tau acetylation, tau phosphorylation, and immunotherapy, such as using adeno-associated virus vectors to deliver anti-p-tau antibodies.</p>
        <p>The best modality for minimizing the incidence of CTE is through strict adherence to preventive measures and safe practices.<xref ref-type="bibr" rid="article-28386.r14">[14]</xref>&#x000a0;Establishing mandatory provisions for a safe playing environment and strictly upholding "return-to-play" policies are paramount.<xref ref-type="bibr" rid="article-28386.r12">[12]</xref></p>
      </sec>
      <sec id="article-28386.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>In addition to a single traumatic brain injury, conditions with clinical features that mimic CTE include:<xref ref-type="bibr" rid="article-28386.r28">[28]</xref><xref ref-type="bibr" rid="article-28386.r29">[29]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Alzheimer disease.</p>
          </list-item>
          <list-item>
            <p>Frontotemporal lobar degeneration.</p>
          </list-item>
          <list-item>
            <p>Lewy body disease.</p>
          </list-item>
          <list-item>
            <p>Cerebral amyloid angiopathy.</p>
          </list-item>
          <list-item>
            <p>Parkinsonism.</p>
          </list-item>
          <list-item>
            <p>Age-related tau astrogliopathy, characterized by subpial "thorn-shaped astrocytes" with purely astrocytic perivascular p-tau pathology, is observed. Moreover, 47% of these lesions are restricted to the midbrain, whereas current criteria for CTE require at least 1 pathognomonic cortical lesion.</p>
          </list-item>
          <list-item>
            <p>Limbic-predominant age-related TDP-43 encephalopathy with neuropathologic changes associated with hippocampal sclerosis.</p>
          </list-item>
          <list-item>
            <p>Bulbar amyotrophic lateral sclerosis.</p>
          </list-item>
          <list-item>
            <p>Primary age-related tauopathy (PART).<xref ref-type="bibr" rid="article-28386.r3">[3]</xref><xref ref-type="bibr" rid="article-28386.r30">[30]</xref></p>
          </list-item>
        </list>
        <p>The characteristic finding that helps differentiate CTE from other tauopathies, such as Alzheimer and Lewy body dementia, is the perivascular deposition of tau-immunoreactive astrocytes within the sulcal depths of superficial cortical layers.<xref ref-type="bibr" rid="article-28386.r11">[11]</xref>&#x000a0;Additionally, the dimensions of NFTs in CTE are larger and are associated with co-localized aggregates of TDP-43.<xref ref-type="bibr" rid="article-28386.r11">[11]</xref> Concurrent neurodegenerative diseases are observed in almost 40% of CTE cases.<xref ref-type="bibr" rid="article-28386.r3">[3]</xref>&#x000a0;However, CTE remains a unique tauopathy&#x02014;both ultrastructurally and microscopically.<xref ref-type="bibr" rid="article-28386.r3">[3]</xref>&#x000a0;</p>
        <p>The tau filament in CTE features a unique &#x003b2;-helix region with a hydrophobic cavity.<xref ref-type="bibr" rid="article-28386.r14">[14]</xref><xref ref-type="bibr" rid="article-28386.r27">[27]</xref>&#x000a0;CTE exhibits higher levels of p-tau in the CA2 and CA3 regions of the hippocampus compared to CA1 and subiculum in Alzheimer disease. Similarly, CA3 and CA4 regions have significantly higher p-tau burden in CTE than&#x000a0;PART.<xref ref-type="bibr" rid="article-28386.r3">[3]</xref></p>
      </sec>
      <sec id="article-28386.s11" sec-type="Pertinent Studies and Ongoing Trials">
        <title>Pertinent Studies and Ongoing Trials</title>
        <p>
<bold>NEurodegeneration: Traumatic Brain Injury as Origin of the Neuropathology (NEwTON)</bold>
</p>
        <p>NEwTON is a prospective study recruiting patients at risk for developing CTE.<xref ref-type="bibr" rid="article-28386.r31">[31]</xref>&#x000a0;Similarly, the "Diagnostics, Imaging, and Genetics Network for the Objective Study and Evaluation of Chronic Traumatic Encephalopathy (DIAGNOSE CTE)'' research project aims to&#x000a0;provide newer insights into CTE's pathogenesis and natural history.<xref ref-type="bibr" rid="article-28386.r32">[32]</xref></p>
      </sec>
      <sec id="article-28386.s12" sec-type="Staging">
        <title>Staging</title>
        <p>The following 4 stages of CTE are described according to the distribution of NFTs and associated clinical signs and symptoms:</p>
        <list list-type="bullet">
          <list-item>
            <p>Stage I: Perivascular deposits of NFTs in the sulcal depths characterized by headache and loss of concentration.</p>
          </list-item>
          <list-item>
            <p>Stage II: Stage I features plus NFTs within the nucleus basalis of Meynert and locus coeruleus, with mood swings and short-term memory loss.</p>
          </list-item>
          <list-item>
            <p>Stage III: Stage II features plus atrophy, wasting of the corpus callosum, septal abnormalities, ventriculomegaly, depigmentation of the substantia nigra, and widespread deposition of p-tau, characterized by cognitive impairment, executive dysfunction, and visuospatial abnormalities.</p>
          </list-item>
          <list-item>
            <p>Stage IV: Stage III features plus further atrophy, gliosis, and hippocampal sclerosis, characterized by profound memory loss and florid parkinsonian features.<xref ref-type="bibr" rid="article-28386.r1">[1]</xref></p>
          </list-item>
        </list>
        <p>McKee described the following 4 pathological stages of CTE:</p>
        <list list-type="bullet">
          <list-item>
            <p>Stage I: Perivascular p-tau deposits in the sulci, primarily within the superior dorsolateral and inferior frontal cortices.</p>
          </list-item>
          <list-item>
            <p>Stage II: Mild ventricular enlargement and changes in the septum pellucidum.</p>
          </list-item>
          <list-item>
            <p>Stage III: Progressive ventricular enlargement, mild frontal and temporal atrophy, and NFT deposits within the olfactory bulb, entorhinal cortex, hippocampus, amygdala, and mammillary bodies.</p>
          </list-item>
          <list-item>
            <p>Stage IV: Diffuse cortical atrophy and complete depigmentation of the locus coeruleus and substantia nigra.<xref ref-type="bibr" rid="article-28386.r6">[6]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28386.s13" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The incidence of mortality among former players has been observed to be 3 times higher than their healthy counterparts. Furthermore, studies have demonstrated a&#x000a0;link between CTE and the development of early-onset Parkinsonian dementia.<xref ref-type="bibr" rid="article-28386.r33">[33]</xref></p>
      </sec>
      <sec id="article-28386.s14" sec-type="Complications">
        <title>Complications</title>
        <p>CTE is progressive in approximately 68% of patients. In a small subgroup with predominantly behavioral or mood symptoms, the condition may remain stable for years before progressing to other stages after a latency of 11 to 14 years.<xref ref-type="bibr" rid="article-28386.r1">[1]</xref> The neurodegenerative process sequentially progresses through stages of social instability and behavioral changes before advancing to dementia.<xref ref-type="bibr" rid="article-28386.r1">[1]</xref> Additionally, there is an increased risk of suicide among these&#x000a0;subsets&#x000a0;of patients.</p>
      </sec>
      <sec id="article-28386.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Preventive measures for high-risk cohorts are the cornerstone of CTE management. Promoting a safe playing environment, strict adherence to concussion reporting, early diagnosis, and mandatory implementation of the "return-to-play" protocol are crucial in minimizing the incidence of CTE.<xref ref-type="bibr" rid="article-28386.r5">[5]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-28386.s16" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Despite recent attention and resources devoted to CTE, significant progress in understanding the disease remains limited. Many perspectives continue to rely on assumptions rather than facts, as Corsellis argued 4 decades ago.<xref ref-type="bibr" rid="article-28386.r15">[15]</xref> However, tau imaging and relevant cerebrospinal fluid&#x000a0;biomarkers have shown promise as potential surrogate markers for the supportive diagnosis of CTE.<xref ref-type="bibr" rid="article-28386.r1">[1]</xref></p>
      </sec>
      <sec id="article-28386.s17" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional team approach is essential for enhancing patient-centered care and outcomes for individuals with CTE. Physicians, advanced practitioners, nurses, pharmacists, and other healthcare professionals must collaborate to develop a comprehensive strategy emphasizing teamwork and communication. Given the inherent heterogeneity of CTE, healthcare team members should leverage their expertise to create individualized care plans that address each patient's unique needs. This approach includes implementing effective concussion reporting systems and adhering to "return-to-play" protocols to ensure safety for high-risk populations.</p>
        <p>Additionally, ongoing education and training in cognitive rehabilitation techniques can empower healthcare clinicians to deliver effective cognitive interventions. As research advances in targeting tau protein oligomerization and propagation, the healthcare team must stay informed about emerging therapies and biomarkers, facilitating timely interventions. Regular interprofessional meetings can foster open communication, allowing healthcare team members to discuss patient progress, share insights from longitudinal studies, and coordinate care effectively. By prioritizing patient safety and team performance, healthcare professionals can significantly improve the management of CTE, ultimately enhancing the quality of care and outcomes for affected individuals.</p>
      </sec>
      <sec id="article-28386.s18">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28386&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28386">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/neurology/repetitive-head-injury-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=28386">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28386/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28386">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-28386.s19">
        <fig id="article-28386.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Chronic Traumatic Encephalopathy. The brain dissection images show a normal brain on the left and a brain with stage IV chronic traumatic encephalopathy (CTE) on the right. Boston University Chronic Traumatic Encephalopathy Center and Brain Bank., <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://commons.wikimedia.org/wiki/File:Chronic_Traumatic_Encephalopathy.png">Public Domain</ext-link>, via Wikimedia Commons</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CTE2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-28386.s20">
        <title>References</title>
        <ref id="article-28386.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Turk</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Budson</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Chronic Traumatic Encephalopathy.</article-title>
            <source>Continuum (Minneap Minn)</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>187</fpage>
            <page-range>187-207</page-range>
            <pub-id pub-id-type="pmid">30707193</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miyata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takahata</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>[Challenges of Diagnostic Imaging of Chronic Traumatic Encephalopathy].</article-title>
            <source>Brain Nerve</source>
            <year>2023</year>
            <month>Jun</month>
            <volume>75</volume>
            <issue>6</issue>
            <fpage>769</fpage>
            <page-range>769-778</page-range>
            <pub-id pub-id-type="pmid">37287361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McKee</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Huber</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Crary</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Bieniek</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dickson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Alvarez</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Cherry</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Farrell</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Uretsky</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abdolmohammadi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Alosco</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Tripodis</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Daneshvar</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Chronic traumatic encephalopathy (CTE): criteria for neuropathological diagnosis and relationship to repetitive head impacts.</article-title>
            <source>Acta Neuropathol</source>
            <year>2023</year>
            <month>Apr</month>
            <volume>145</volume>
            <issue>4</issue>
            <fpage>371</fpage>
            <page-range>371-394</page-range>
            <pub-id pub-id-type="pmid">36759368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Katz</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Bernick</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dodick</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Mez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mariani</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Adler</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Alosco</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Balcer</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Banks</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Barr</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Brody</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Cantu</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Dams-O'Connor</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Geda</surname>
                <given-names>YE</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>McAllister</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Peskind</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Wethe</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Zafonte</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Foley</surname>
                <given-names>&#x000c9;M</given-names>
              </name>
              <name>
                <surname>Babcock</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Koroshetz</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Tripodis</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>McKee</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Shenton</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Cummings</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Reiman</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Stern</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome.</article-title>
            <source>Neurology</source>
            <year>2021</year>
            <month>May</month>
            <day>04</day>
            <volume>96</volume>
            <issue>18</issue>
            <fpage>848</fpage>
            <page-range>848-863</page-range>
            <pub-id pub-id-type="pmid">33722990</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eaton</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Lonser</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>History of biological, mechanistic, and clinical understanding of concussion.</article-title>
            <source>Neurosurg Focus</source>
            <year>2024</year>
            <month>Jul</month>
            <volume>57</volume>
            <issue>1</issue>
            <fpage>E2</fpage>
            <pub-id pub-id-type="pmid">38950436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arciniega</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Baucom</surname>
                <given-names>ZH</given-names>
              </name>
              <name>
                <surname>Tuz-Zahra</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tripodis</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>John</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Carrington</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Knyazhanskaya</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Breedlove</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wiegand</surname>
                <given-names>TLT</given-names>
              </name>
              <name>
                <surname>Daneshvar</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Rushmore</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Billah</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pasternak</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Coleman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Adler</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Bernick</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Balcer</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Alosco</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Koerte</surname>
                <given-names>IK</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Cummings</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Reiman</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Stern</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Shenton</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Bouix</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Brain morphometry in former American football players: findings from the DIAGNOSE CTE research project.</article-title>
            <source>Brain</source>
            <year>2024</year>
            <month>Oct</month>
            <day>03</day>
            <volume>147</volume>
            <issue>10</issue>
            <fpage>3596</fpage>
            <page-range>3596-3610</page-range>
            <pub-id pub-id-type="pmid">38533783</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Daneshvar</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Kiernan</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Abdolmohammadi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Alvarez</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Huber</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Alosco</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Solomon</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Nowinski</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>McHale</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cormier</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Kubilus</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Baugh</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Montenigro</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Chaisson</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Tripodis</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kowall</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>Weuve</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McClean</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Cantu</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Stern</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>McKee</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Clinicopathological Evaluation of Chronic Traumatic Encephalopathy in Players of American Football.</article-title>
            <source>JAMA</source>
            <year>2017</year>
            <month>Jul</month>
            <day>25</day>
            <volume>318</volume>
            <issue>4</issue>
            <fpage>360</fpage>
            <page-range>360-370</page-range>
            <pub-id pub-id-type="pmid">28742910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castellani</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges.</article-title>
            <source>J Alzheimers Dis</source>
            <year>2019</year>
            <volume>67</volume>
            <issue>2</issue>
            <fpage>447</fpage>
            <page-range>447-467</page-range>
            <pub-id pub-id-type="pmid">30584140</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruchika</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Neupane</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vijay</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mehkri</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lucke-Wold</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Understanding the Molecular Progression of Chronic Traumatic Encephalopathy in Traumatic Brain Injury, Aging and Neurodegenerative Disease.</article-title>
            <source>Int J Mol Sci</source>
            <year>2023</year>
            <month>Jan</month>
            <day>17</day>
            <volume>24</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">36768171</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blaylock</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Maroon</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis.</article-title>
            <source>Surg Neurol Int</source>
            <year>2011</year>
            <volume>2</volume>
            <fpage>107</fpage>
            <pub-id pub-id-type="pmid">21886880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tharmaratnam</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Iskandar</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Tabobondung</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Tobbia</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gopee-Ramanan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tabobondung</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <article-title>Chronic Traumatic Encephalopathy in Professional American Football Players: Where Are We Now?</article-title>
            <source>Front Neurol</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>445</fpage>
            <pub-id pub-id-type="pmid">29971037</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saulle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Greenwald</surname>
                <given-names>BD</given-names>
              </name>
            </person-group>
            <article-title>Chronic traumatic encephalopathy: a review.</article-title>
            <source>Rehabil Res Pract</source>
            <year>2012</year>
            <volume>2012</volume>
            <fpage>816069</fpage>
            <pub-id pub-id-type="pmid">22567320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Omalu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bailes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Kamboh</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Hammers</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Case</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fitzsimmons</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Emerging histomorphologic phenotypes of chronic traumatic encephalopathy in American athletes.</article-title>
            <source>Neurosurgery</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>69</volume>
            <issue>1</issue>
            <fpage>173</fpage>
            <page-range>173-83; discussion 183</page-range>
            <pub-id pub-id-type="pmid">21358359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fesharaki-Zadeh</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Navigating the Complexities of Traumatic Encephalopathy Syndrome (TES): Current State and Future Challenges.</article-title>
            <source>Biomedicines</source>
            <year>2023</year>
            <month>Nov</month>
            <day>27</day>
            <volume>11</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">38137378</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Corsellis</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bruton</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Freeman-Browne</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The aftermath of boxing.</article-title>
            <source>Psychol Med</source>
            <year>1973</year>
            <month>Aug</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>270</fpage>
            <page-range>270-303</page-range>
            <pub-id pub-id-type="pmid">4729191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eggers</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Redrawing Papez' circuit: a theory about how acute stress becomes chronic and causes disease.</article-title>
            <source>Med Hypotheses</source>
            <year>2007</year>
            <volume>69</volume>
            <issue>4</issue>
            <fpage>852</fpage>
            <page-range>852-7</page-range>
            <pub-id pub-id-type="pmid">17376605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Montenigro</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Baugh</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Daneshvar</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Mez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Budson</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Au</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Cantu</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Stern</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Clinical subtypes of chronic traumatic encephalopathy: literature review and proposed research diagnostic criteria for traumatic encephalopathy syndrome.</article-title>
            <source>Alzheimers Res Ther</source>
            <year>2014</year>
            <volume>6</volume>
            <issue>5</issue>
            <fpage>68</fpage>
            <pub-id pub-id-type="pmid">25580160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schaffert</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Didehbani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>LoBue</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rossetti</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lacritz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cullum</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Frequency and Predictors of Traumatic Encephalopathy Syndrome in a Prospective Cohort of Retired Professional Athletes.</article-title>
            <source>Front Neurol</source>
            <year>2021</year>
            <volume>12</volume>
            <fpage>617526</fpage>
            <pub-id pub-id-type="pmid">33708171</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cherry</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Tripodis</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Alvarez</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Huber</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Au</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kiernan</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Daneshvar</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Mez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Solomon</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Alosco</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>McKee</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease.</article-title>
            <source>PLoS One</source>
            <year>2017</year>
            <volume>12</volume>
            <issue>9</issue>
            <fpage>e0185541</fpage>
            <pub-id pub-id-type="pmid">28950005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alosco</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Tripodis</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Fritts</surname>
                <given-names>NG</given-names>
              </name>
              <name>
                <surname>Heslegrave</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baugh</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Conneely</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mariani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Frank</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Cantu</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>McKee</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Trojanowski</surname>
                <given-names>JQ</given-names>
              </name>
              <name>
                <surname>Blennow</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zetterberg</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Stern</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Cerebrospinal fluid tau, A&#x003b2;, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration.</article-title>
            <source>Alzheimers Dement</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>14</volume>
            <issue>9</issue>
            <fpage>1159</fpage>
            <page-range>1159-1170</page-range>
            <pub-id pub-id-type="pmid">30049650</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alosco</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Protas</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cherry</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Adler</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Balcer</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Bernick</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pulukuri</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Abdolmohammadi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Coleman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Palmisano</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Tripodis</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Mez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rabinovici</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Marek</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Beach</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Huber</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Koerte</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Bouix</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cummings</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Shenton</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Reiman</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>McKee</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Stern</surname>
                <given-names>RA</given-names>
              </name>
              <collab>DIAGNOSE C. T. E. Research Project</collab>
            </person-group>
            <article-title>Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2023</year>
            <month>Jan</month>
            <volume>50</volume>
            <issue>2</issue>
            <fpage>435</fpage>
            <page-range>435-452</page-range>
            <pub-id pub-id-type="pmid">36152064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asken</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Rabinovici</surname>
                <given-names>GD</given-names>
              </name>
            </person-group>
            <article-title>Identifying degenerative effects of repetitive head trauma with neuroimaging: a clinically-oriented review.</article-title>
            <source>Acta Neuropathol Commun</source>
            <year>2021</year>
            <month>May</month>
            <day>22</day>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>96</fpage>
            <pub-id pub-id-type="pmid">34022959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Su</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Protas</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Alosco</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Adler</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Balcer</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Bernick</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Au</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Banks</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Barr</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Coleman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Dodick</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Marek</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>McClean</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>McKee</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Mez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Daneshvar</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Palmisano</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Peskind</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Wethe</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Rabinovici</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tripodis</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Cummings</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Shenton</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Stern</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Reiman</surname>
                <given-names>EM</given-names>
              </name>
              <collab>DIAGNOSE CTE Research Project Investigators</collab>
            </person-group>
            <article-title>Flortaucipir tau PET findings from former professional and college American football players in the DIAGNOSE CTE research project.</article-title>
            <source>Alzheimers Dement</source>
            <year>2024</year>
            <month>Mar</month>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>1827</fpage>
            <page-range>1827-1838</page-range>
            <pub-id pub-id-type="pmid">38134231</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shahim</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gill</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Blennow</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zetterberg</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Fluid Biomarkers for Chronic Traumatic Encephalopathy.</article-title>
            <source>Semin Neurol</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>40</volume>
            <issue>4</issue>
            <fpage>411</fpage>
            <page-range>411-419</page-range>
            <pub-id pub-id-type="pmid">32740901</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ge</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Qiang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yin</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lei</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Potential blood biomarkers for chronic traumatic encephalopathy: The multi-omics landscape of an observational cohort.</article-title>
            <source>Front Aging Neurosci</source>
            <year>2022</year>
            <volume>14</volume>
            <fpage>1052765</fpage>
            <pub-id pub-id-type="pmid">36420308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shahim</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zetterberg</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Simr&#x000e9;n</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ashton</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Norato</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sch&#x000f6;ll</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tegner</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Diaz-Arrastia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Blennow</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Association of Plasma Biomarker Levels With Their CSF Concentration and the Number and Severity of Concussions in Professional Athletes.</article-title>
            <source>Neurology</source>
            <year>2022</year>
            <month>Jul</month>
            <day>26</day>
            <volume>99</volume>
            <issue>4</issue>
            <fpage>e347</fpage>
            <page-range>e347-e354</page-range>
            <pub-id pub-id-type="pmid">35654597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Falcon</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zivanov</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Murzin</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Garringer</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Vidal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Crowther</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Newell</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Ghetti</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Goedert</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Scheres</surname>
                <given-names>SHW</given-names>
              </name>
            </person-group>
            <article-title>Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules.</article-title>
            <source>Nature</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>568</volume>
            <issue>7752</issue>
            <fpage>420</fpage>
            <page-range>420-423</page-range>
            <pub-id pub-id-type="pmid">30894745</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>S&#x000e1;inz Pelayo</surname>
                <given-names>MDP</given-names>
              </name>
              <name>
                <surname>Pelayo Vergara</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Albu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Figueira</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>[Experience with 4 clinical cases. Traumatic encephalopathy may be associated with a single traumatic brain injury?].</article-title>
            <source>Rehabilitacion (Madr)</source>
            <year>2022</year>
            <season>Oct-Dec</season>
            <volume>56</volume>
            <issue>4</issue>
            <fpage>383</fpage>
            <page-range>383-387</page-range>
            <pub-id pub-id-type="pmid">34538654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peacock</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Kuehl</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bazarian</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Cannon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rafique</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>d'Etienne</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Welch</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Diaz-Arrastia</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Defining Acute Traumatic Encephalopathy: Methods of the "HEAD Injury Serum Markers and Multi-Modalities for Assessing Response to Trauma" (HeadSMART II) Study.</article-title>
            <source>Front Neurol</source>
            <year>2021</year>
            <volume>12</volume>
            <fpage>733712</fpage>
            <pub-id pub-id-type="pmid">34956041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asken</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Tanner</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>VandeVrede</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Casaletto</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Staffaroni</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Mundada</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fonseca</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Iaccarino</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>La Joie</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tsuei</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mladinov</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grant</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shankar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>KKW</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cobigo</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gardner</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Spina</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Seeley</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Grinberg</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Rabinovici</surname>
                <given-names>GD</given-names>
              </name>
            </person-group>
            <article-title>Multi-Modal Biomarkers of Repetitive Head Impacts and Traumatic Encephalopathy Syndrome: A Clinicopathological Case Series.</article-title>
            <source>J Neurotrauma</source>
            <year>2022</year>
            <month>Sep</month>
            <volume>39</volume>
            <issue>17-18</issue>
            <fpage>1195</fpage>
            <page-range>1195-1213</page-range>
            <pub-id pub-id-type="pmid">35481808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Amerongen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Caton</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Ossenkoppele</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Barkhof</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pouwels</surname>
                <given-names>PJW</given-names>
              </name>
              <name>
                <surname>Teunissen</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Rozemuller</surname>
                <given-names>AJM</given-names>
              </name>
              <name>
                <surname>Hoozemans</surname>
                <given-names>JJM</given-names>
              </name>
              <name>
                <surname>Pijnenburg</surname>
                <given-names>YAL</given-names>
              </name>
              <name>
                <surname>Scheltens</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vijverberg</surname>
                <given-names>EGB</given-names>
              </name>
            </person-group>
            <article-title>Rationale and design of the "NEurodegeneration: Traumatic brain injury as Origin of the Neuropathology (NEwTON)" study: a prospective cohort study of individuals at risk for chronic traumatic encephalopathy.</article-title>
            <source>Alzheimers Res Ther</source>
            <year>2022</year>
            <month>Sep</month>
            <day>01</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>119</fpage>
            <pub-id pub-id-type="pmid">36050790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alosco</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Mariani</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Adler</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Balcer</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Bernick</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Au</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Banks</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Barr</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Bouix</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cantu</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Coleman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Dodick</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Farrer</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Geda</surname>
                <given-names>YE</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Koerte</surname>
                <given-names>IK</given-names>
              </name>
              <name>
                <surname>Kowall</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Marcus</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Marek</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>McClean</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>McKee</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Mez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Palmisano</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Peskind</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Tripodis</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Wethe</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Cummings</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Reiman</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Shenton</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Stern</surname>
                <given-names>RA</given-names>
              </name>
              <collab>DIAGNOSE CTE Research Project Investigators</collab>
            </person-group>
            <article-title>Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project.</article-title>
            <source>Alzheimers Res Ther</source>
            <year>2021</year>
            <month>Aug</month>
            <day>12</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>136</fpage>
            <pub-id pub-id-type="pmid">34384490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28386.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adams</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Alvarez</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Mez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Huber</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Tripodis</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Meng</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kubilus</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Cormier</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kiernan</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Daneshvar</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Chua</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Svirsky</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nicks</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Abdolmohammadi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Evers</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Solomon</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Cherry</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Aytan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mahar</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Devine</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Auerbach</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alosco</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Nowinski</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Kowall</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Dwyer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Cantu</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Stern</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Au</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>McKee</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>TD</given-names>
              </name>
            </person-group>
            <article-title>Lewy Body Pathology and Chronic Traumatic Encephalopathy Associated With Contact Sports.</article-title>
            <source>J Neuropathol Exp Neurol</source>
            <year>2018</year>
            <month>Sep</month>
            <day>01</day>
            <volume>77</volume>
            <issue>9</issue>
            <fpage>757</fpage>
            <page-range>757-768</page-range>
            <pub-id pub-id-type="pmid">30053297</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
